Erasca, Inc. (ERAS)
10.11
-0.12
(-1.17%)
USD |
NASDAQ |
May 18, 15:09
Erasca Research and Development Expense (Quarterly) : 27.26M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 341.62M |
| Tango Therapeutics, Inc. | 33.07M |
| Scholar Rock Holding Corp. | 51.48M |
| Kymera Therapeutics, Inc. | 96.14M |
| Relay Therapeutics, Inc. | 70.56M |